Ultherapy vs Sofwave: Comparing Ultrasound and Radiofrequency Skin Tightening

Ultherapy (Ulthera, now part of Merz) delivers high-intensity focused ultrasound at 4 MHz and 7 MHz frequencies. The device concentrates acoustic energy into precise focal zones at depths of 1.5 mm (epidermis), 3 mm (mid-dermis), and 4.5 mm (deep dermis and SMAS). Energy is absorbed by tissue, generating heat that denatures collagen and triggers neocollagenesis. Because ultrasound travels in a straight line and focuses at a fixed depth, Ultherapy creates a predictable thermal injury pattern, which is the appeal for consistent lifting, especially in the subdermal and SMAS planes.

Sofwave (InMode) combines bipolar radiofrequency with microneedling. The device uses 2 MHz RF energy delivered through an array of microneedles that penetrate to 1.5 mm depth. The RF energy heats tissue in the dermis and superficial subcutis, triggering collagen contraction and remodeling. The microneedle channels also create controlled micro-injuries that amplify the inflammatory cascade and fibroblast activation, a dual mechanism that accelerates collagen synthesis.

Comfort and Downtime

Ultherapy is the more uncomfortable procedure. Focused ultrasound generates significant heat at depth, and patients report moderate to severe pain during treatment, particularly on sensitive areas like the neck and jawline. Most practices use topical anesthesia plus oral or IV sedation to manage discomfort. Treatment time is 30–60 minutes depending on area size. Downtime is minimal; mild erythema and edema resolve within hours to a day.

Sofwave is substantially more comfortable. Microneedle RF generates less acute pain because energy is distributed across multiple needle channels rather than concentrated in a focal point. Patients typically tolerate the procedure with topical anesthesia alone, and some practices apply no anesthesia at all. Treatment time is 20–40 minutes. Downtime is also minimal: mild erythema and temporary needle marks fade within 24-48 hours.

Clinical Results and Depth of Action

Ultherapy excels at deep, structural lifting because HIFU can reliably reach the SMAS layer (4.5 mm depth). This makes it the preferred choice for jawline definition, neck laxity, and mild to moderate skin sagging. Results are visible immediately (from collagen contraction) and improve over 12 weeks as new collagen deposits. Durability is typically 6–12 months, with many patients seeing benefit up to 18 months. One treatment is often sufficient for a season or year.

Sofwave delivers more diffuse, dermal-level tightening and is particularly effective for fine lines, skin texture, and early-stage laxity. Because it doesn't reach the SMAS as reliably, it's less effective for severe sagging. Results build over 4–8 weeks as collagen remodels. Durability is similar, 6-12 months, but the mechanism favors repeat treatments at 6-month intervals to maintain results. Sofwave also pairs well with toxin and filler, making it a natural add-on in a comprehensive facial-rejuvenation plan.

Practice Economics

Ultherapy has a higher device acquisition cost (typically $150,000–$200,000 for a new system) and lower per-treatment revenue ($1,500–$3,000 depending on area and depth). The high upfront investment and longer treatment time mean break-even requires consistent patient volume.

Sofwave systems cost $80,000–$120,000 and support per-treatment fees of $1,200–$2,500, with faster throughput and easier stacking into combination treatments. The lower capital requirement and higher per-hour revenue make Sofwave more accessible for smaller practices.

The Bottom Line

Choose Ultherapy if your patient base seeks dramatic jawline and neck lifting, tolerates discomfort, and wants a single annual treatment. Choose Sofwave if you prioritize patient comfort, want faster treatment cycles, and aim to integrate skin tightening into a broader aesthetic menu. Many high-volume practices run both: Ultherapy for the structural-lift segment and Sofwave for the texture-and-maintenance cohort.